mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |